National Cancer Registration and Analysis Service, Public Health England, Wellington House, London, United Kingdom.
International Prevention Research Institute, Lyon, France.
JAMA Dermatol. 2019 Mar 1;155(3):298-306. doi: 10.1001/jamadermatol.2018.4219.
Cutaneous squamous cell carcinoma (cSCC) is the most common skin cancer with metastatic potential, but epidemiologic data are poor. Changes to the National Cancer Registration and Analysis Service (NCRAS) in England have allowed more accurate data analysis of primary and metastatic cSCC since 2013.
To assess the national incidence of cSCC and metastatic cSCC (mcSCC) in England from 2013 through 2015.
DESIGN, SETTING, AND PARTICIPANTS: This national population-based study identified a cohort of patients with cSCC and mcSCC in England from January 1, 2013, through December 31, 2015. Patients were identified using diagnostic codes derived from pathology reports in the NCRAS. Data were analyzed from March 1, 2017, through March 1, 2018.
Incidence rates across sex and risk factors for cSCC were derived from the NCRAS data. Risk of occurrence of mcSCC among the population with cSCC was assessed with Cox proportional hazards regression analysis to determine indicators of mcSCC.
Among the 76 977 patients with first primary cSCC in 2013 through 2015 (62.7% male; median age, 80 years [interquartile range, 72-86 years]), the age-standardized rates for the first registered cSCC in England from 2013 through 2015 were 77.3 per 100 000 person-years (PY) (95% CI, 76.6-78.0) in male patients and 34.1 per 100 000 PY (95% CI, 33.7-34.5) in female patients. Increased primary cSCC tumor count was observed in older, white male patients in lower deprivation quintiles. After a maximum follow-up of 36 months, cumulative incidence of mcSCC developed in 1.1% of women and 2.4% of men with a primary cSCC. Significant increases in the risk of metastasis with adjusted hazard rates of approximately 2.00 were observed in patients who were aged 80 to 89 years (hazard ratio [HR], 1.23; 95% CI, 1.07-1.43), 90 years or older (HR, 1.35; 95% CI, 1.09-1.66), male (HR, 1.79; 95% CI, 1.52-2.10), immunosuppressed (HR, 1.99; 95% CI, 1.64-2.42), and in higher deprivation quintiles (HR for highest quintile, 1.64; 95% CI, 1.35-2.00). Primary cSCC located on the ear (HR, 1.70; 95% CI, 1.42-2.03) and lip (HR, 1.85; 95% CI, 1.29-2.63) were at highest risk of metastasis.
This study presents the first national study of the incidence of mcSCC. With limited health care resources and an aging population, accurate epidemiologic data are essential for informing future health care planning, identifying high-risk patients, and evaluating skin cancer prevention policies.
皮肤鳞状细胞癌(cSCC)是最常见的具有转移潜能的皮肤癌,但流行病学数据很少。自 2013 年以来,英格兰国家癌症登记和分析服务局(NCRAS)的变更允许对原发性和转移性 cSCC 进行更准确的数据分析。
评估 2013 年至 2015 年英格兰 cSCC 和转移性 cSCC(mcSCC)的全国发病率。
设计、地点和参与者:本项全国性基于人群的研究从 2013 年 1 月 1 日至 2015 年 12 月 31 日,在英格兰确定了一组 cSCC 和 mcSCC 患者。患者是使用 NCRAS 中的病理报告得出的诊断代码确定的。数据分析于 2017 年 3 月 1 日至 2018 年 3 月 1 日进行。
从 NCRAS 数据中得出了 cSCC 跨性别和危险因素的发病率。使用 Cox 比例风险回归分析评估了 cSCC 人群中发生 mcSCC 的风险,以确定 mcSCC 的指标。
在 2013 年至 2015 年期间首次确诊为原发性 cSCC 的 76977 例患者中(62.7%为男性;中位年龄为 80 岁[四分位距,72-86 岁]),2013 年至 2015 年英格兰首次登记的 cSCC 的年龄标准化率为男性患者为每 100000 人年 77.3 例(95%CI,76.6-78.0),女性患者为每 100000 人年 34.1 例(95%CI,33.7-34.5)。在较低贫困五分位数的老年白人男性患者中,观察到原发性 cSCC 肿瘤数量增加。在最大 36 个月的随访后,1.1%的女性和 2.4%的男性原发性 cSCC 患者发展为 mcSCC。与调整后的危险比约为 2.00 相比,观察到 80 至 89 岁(HR,1.23;95%CI,1.07-1.43)、90 岁或以上(HR,1.35;95%CI,1.09-1.66)、男性(HR,1.79;95%CI,1.52-2.10)、免疫抑制(HR,1.99;95%CI,1.64-2.42)和较高的贫困五分位数(HR 最高五分位数,1.64;95%CI,1.35-2.00)的患者发生转移的风险显著增加。位于耳朵(HR,1.70;95%CI,1.42-2.03)和嘴唇(HR,1.85;95%CI,1.29-2.63)的原发性 cSCC 转移风险最高。
本研究首次报告了 mcSCC 的全国发病率。由于医疗保健资源有限且人口老龄化,准确的流行病学数据对于为未来的医疗保健规划提供信息、确定高风险患者以及评估皮肤癌预防政策至关重要。